English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51901718    線上人數 :  1014
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"liu c j"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 861-870 / 1268 (共127頁)
<< < 82 83 84 85 86 87 88 89 90 91 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-03-02T06:12:17Z Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate Wen W.-H.; Chen H.-L.; Shih T.T.-F.; Wu J.-F.; Ni Y.-H.; Lee C.-N.; Zhao L.-L.; Lai M.-W.; Mu S.-C.; Tung Y.-C.; Hsu H.-Y.; Chang M.-H.; MING-KWANG SHYU; Hwa H.L.; Su Y.N.; Shih J.C.; Chao K.H.; Chiu Y.C.; Chang K.C.; Liu C.J.; Su T.H.; Chen D.S.; Chen S.M.; Lin C.C.; Lin P.Y.; Yang W.R.; Hu J.J.; Yang C.K.; Chang Y.K.; Chen K.H.; Lin H.H.; Lin Y.H.; Chen H.J.; Pan H.S.; Lau B.H.; Lee C.L.; Cheng P.J.; Chang Y.L.; Chiueh H.Y.; Wang T.H.; Hsu J.J.; Lo L.M.; Hsieh C.L.; Cheng S.W.; Tsai M.S.; Lin L.H.; She B.Q.; Peng F.S.; Lin Y.C.; Chen C.P.; Huang J.P.; Yeung C.Y.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study)
臺大學術典藏 2021-02-26T02:00:31Z Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: In comparison with ceftazidime treatment Chang S.-C.; Fang C.-T.; Hsueh P.-R.; Liu C.-J.; WANG-HUEI SHENG; Hsieh S.-M.; Hung C.-C.; Chen Y.-C.
臺大學術典藏 2021-02-26T02:00:29Z Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections Fang C.-T.;Chen Y.-C.;Lin S.-F.;Shau W.-Y.;Liu C.-J.;Wang-Huei Sheng;Wang J.-T.;Chang S.-C.; Fang C.-T.; Chen Y.-C.; Lin S.-F.; Shau W.-Y.; Liu C.-J.; WANG-HUEI SHENG; Wang J.-T.; Chang S.-C.
臺大學術典藏 2021-02-26T02:00:01Z Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy WANG-HUEI SHENG; Hung C.-C.; Chang S.-Y.; Liu C.-J.; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; Chen P.-J.; Chang S.-C.
臺大學術典藏 2021-02-26T01:59:37Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.;Wang-Huei Sheng;Sun H.-Y.;Hsieh S.-M.;Lo Y.-C.;Liu C.-J.;Su T.-H.;Yang H.-C.;Liu W.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Liu C.-H.; WANG-HUEI SHENG; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-02-26T01:59:31Z Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii Chien J.-Y.;Liu C.-J.;Chuang P.-C.;Lee T.-F.;Huang Y.-T.;Liao C.-H.;Hung C.-C.;Wang-Huei Sheng;Yu C.-J.;Hsueh P.-R.; Chien J.-Y.; Liu C.-J.; Chuang P.-C.; Lee T.-F.; Huang Y.-T.; Liao C.-H.; Hung C.-C.; WANG-HUEI SHENG; Yu C.-J.; Hsueh P.-R.
臺大學術典藏 2021-02-26T01:59:24Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H.;Sun H.-Y.;Liu C.-J.;Wang-Huei Sheng;Hsieh S.-M.;Lo Y.-C.;Liu W.-C.;Su T.-H.;Yang H.-C.;Hong C.-M.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Liu C.-H.; Sun H.-Y.; Liu C.-J.; WANG-HUEI SHENG; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-02-25T07:00:59Z Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan Yu-Yun Shao;Wang S.-Y.;Lin S.-M.;Chen K.-Y.;Tseng J.-H.;Ho M.-C.;Lee R.-C.;Liang P.-C.;Liao L.-Y.;Huang K.-W.;Hu J.-T.;Liang J.-D.;Kee K.-M.;Lin C.-L.;Wang C.-K.;Lu S.-N.;Wang J.-H.;Lee W.-C.;Chen C.-H.;Liu C.-J.;Huang Y.-H.;Wang C.-C.;Wang T.-E.;Chuang P.-H.;Dai C.-Y.;Hsu C.;Chen S.-C.;Hsieh C.-H.;Diagnosis Group, Systemic Therapy Group; YU-YUN SHAO; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏 2021-02-18T08:01:12Z Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; JA-DER LIANG; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group
臺大學術典藏 2021-02-18T02:09:13Z Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan Shao Y.-Y.;Wang S.-Y.;Lin S.-M.;Chen K.-Y.;Tseng J.-H.;Ho M.-C.;Lee R.-C.;Liang P.-C.;Liao L.-Y.;Huang K.-W.;Hu J.-T.;Liang J.-D.;Kee K.-M.;Lin C.-L.;Wang C.-K.;Lu S.-N.;Wang J.-H.;Lee W.-C.;Chen C.-H.;Liu C.-J.;Huang Y.-H.;Wang C.-C.;Wang T.-E.;Chuang P.-H.;Dai C.-Y.;Chiun Hsu;Chen S.-C.;Hsieh C.-H.;Diagnosis Group, Systemic Therapy Group; Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Chiun Hsu; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group

顯示項目 861-870 / 1268 (共127頁)
<< < 82 83 84 85 86 87 88 89 90 91 > >>
每頁顯示[10|25|50]項目